Will New Drugs Drive Pfizer (PFE) Sales in Q4 Earnings?
Pfizer(PFE) Zacks Investment Research·2024-01-29 14:26Pfizer (PFE) has been relying on its newly launched and newly acquired products to improve its sales performance amid a decline in revenues from its COVID-19 products.Pfizer records direct sales and alliance revenues from its partner, BioNTech (BNTX) , for the COVID-19 vaccine, Comirnaty, and product revenues from its oral antiviral pill for COVID, Paxlovid.Investors will be keen to know the sales numbers of Pfizer’s several newly launched drugs like Abrysvo, Velsipity, Penbraya, Zavzpret as well as newly a ...